formed in Sept. 1999 from the merger of Proteus International plc and Therapeutic Antibodies Inc.; parent of Protherics Inc.; acquired Enact Pharma in June 2003; completed expansion of Ceredigion, Wales, UK, immunoglobulin processing facility in summer 2005
